![These stocks are outperforming Nvidia in June](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEH7Q068_L.jpg)
Please try another search
Aspira Pathlab & Diagnostics Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 38.18 million compared to INR 34.08 million a year ago. Revenue was INR 38.94 million compared to INR 34.81 million a year ago. Net loss was INR 5.03 million compared to INR 2.59 million a year ago. Basic loss per share from continuing operations was INR 0.49 compared to INR 0.25 a year ago. Diluted loss per share from continuing operations was INR 0.49 compared to INR 0.25 a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 38.18 | 34.62 | 26.04 | 34.26 |
Gross Profit | 12.51 | 9.03 | 6.55 | 10.5 |
Operating Income | -4.94 | -7.54 | -7.19 | -2.19 |
Net Income | -5.03 | -7.42 | -7.16 | -2.59 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 147.1 | 173.42 | ||
Total Liabilities | 45.91 | |||
Total Equity | 101.43 | 127.5 | 127.5 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review